In addition, we showed in clinical research that insulin therapy at an early stage of diabetes increased the possibility of withdrawal of insulin and that results in glucagon test or casual C-peptide index were useful to predict the possibility of withdrawal from insulin [6, 7]. The gene discussed is INS; the disease is diabetes mellitus.